Immunohistochemistry analysis showed that EIF4E, EIF4E3, and NCBP2 were increased in lower-grade glioma tissues, while lower-grade glioma did not cause a significant difference in EIF4E2 and NCBP1 proteins (Fig. 11A, B). This evidence concerns the gene EIF4E3 and central nervous system cancer.